Reprint
Pathogenesis and Treatment of Chronic Pruritus
Edited by
September 2020
144 pages
- ISBN978-3-03943-100-7 (Hardback)
- ISBN978-3-03943-101-4 (PDF)
This book is a reprint of the Special Issue Pathogenesis and Treatment of Chronic Pruritus that was published in
Medicine & Pharmacology
Public Health & Healthcare
Summary
This Special Edition Issue on the “Pathogenesis and Treatment of Chronic Pruritus” contains an overview of various known causes of chronic pruritus and emerging therapeutics. Chronic pruritus is an itch that lasts longer than six weeks, and is associated with a variety of dermatologic, systemic, neurologic, and psychiatric etiologies. Itch negatively impacts patient quality of life, and has devastating psychosocial consequences. The manuscripts published in this Special Issue are also a showcase of the current understanding of the pathogenesis of chronic pruritus, along with its epidemiology, diagnostic workup, and therapeutic approaches used to treat chronic pruritus. A special focus is also placed on prurigo nodularis, a severely pruritic chronic inflammatory skin disease.
Format
- Hardback
License
© 2020 by the authors; CC BY-NC-ND license
Keywords
dupilumab; IL-4; IL-13; pruritus; chronic pruritus of unknown origin; prurigo nodularis; uremic pruritus; lichen planus; eosinophilic dermatosis of hematologic malignancy; chronic pruritus; mirtazapine; chronic; pruritus; itch; refractory; treatment; noradrenergic; serotonergic; antihistaminergic; antidepressant; chronic pruritus; skin; atopic dermatitis; ceramide; pine tar; pruritus; itch; drug-induced; medication-related; epidemiology; prurigo nodularis; pruritus; itch; inpatient; disease burden; national inpatient sample; medical dermatology; prurigo nodularis; systematic review; itch; pruritus; pruritus; itch; prurigo; nodularis; atopic; dermatitis; race; gender; comorbidities; demographics; itch; pruritus; pediatric; children; malignancy; cancer; neoplasm; epidemiology; uremic pruritus; ion channels; cell signaling; Cav3.2 calcium channel; RT-PCR; skin; chronic pruritus; itch; pruritus; wounds; itch in wounds; itch management; aprepitant; erlotinib; pruritus; EGFR; epidermal growth factor receptor; NK1R; neurokinin1-receptor; mycosis fungoides; atopic dermatitis; psoriasis; associations; comorbidities; epidemiology; lymphomatoid papulosis; lymphoma; racial differences; prurigo nodularis; nodular prurigo; pruritus; itch; neuropathy; pruritus; itch; treatment; therapeutic; pathogenesis; epidemiology